CEO Karen Wurster, Adipo Therapeutics (IMAGE)
Caption
Adipo Therapeutics CEO Karen Wurster. Adipo Therapeutics has successfully raised $1.9 million in bridge funds that will be used to complete critical studies to demonstrate its lead asset can convert energy-storing white adipose tissue to energy-burning brown adipose tissue in human fat.
Credit
(The ESC Plan photo/Charles Jischke)
Usage Restrictions
None
License
Original content